Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-015956
Filing Date
2025-05-12
Accepted
2025-05-12 08:06:37
Documents
98
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q urgn20250331_10q.htm   iXBRL 10-Q 1741344
2 EXHIBIT 10.1 ex_810872.htm EX-10.1 438805
3 EXHIBIT 31.1 ex_771051.htm EX-31.1 17000
4 EXHIBIT 31.2 ex_771052.htm EX-31.2 16995
5 EXHIBIT 32.1 ex_771053.htm EX-32.1 6486
6 EXHIBIT 32.2 ex_771054.htm EX-32.2 6481
  Complete submission text file 0001437749-25-015956.txt   8528765

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA urgn-20250331.xsd EX-101.SCH 79628
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20250331_cal.xml EX-101.CAL 55493
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20250331_def.xml EX-101.DEF 469109
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20250331_lab.xml EX-101.LAB 403152
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20250331_pre.xml EX-101.PRE 512281
101 EXTRACTED XBRL INSTANCE DOCUMENT urgn20250331_10q_htm.xml XML 1106181
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 25932693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)